Pancreatic Cancer Detection Consortium (PCDC)

A 3-dimensional image of a human torso highlighting the pancreas.The Pancreatic Cancer Detection Consortium (PCDC) develops and tests new molecular and imaging biomarkers to detect early stage pancreatic ductal adenocarcinoma (PDAC) and its precursor lesions.  These biomarkers would be used to identify individuals who are at high risk of developing PDAC and are candidates for early intervention.

Read more About PCDC


  • Baylor Scott & White Research Institute/Translational Genomics Research Institute
  • Dana Farber Cancer Institute/Harvard Medical School
  • Johns Hopkins University
  • Mayo Clinic/University of Pennsylvania
  • Stanford University
  • University of California, Davis
  • University of Nebraska Medical Center

More about the Teams


This page is under construction.


  • Structure
  • Steering Committee
  • Consortium Coordinator
  • NCI Program Staff

Learn about Administration

News and Events

This page is under construction.